Equity Issuances

AMERICAN REBEL HOLDINGS INC issued 127,000 shares of Common Stock to SCC of common stock to Silverback Capital Corporation ("SCC") for payment of approximately $126,358.65.

“On February 4, 2026, Silverback Capital Corporation ("SCC"), pursuant to the Settlement Agreement and Stipulation dated as of October 28, 2025, as amended, requested the issuance of 127,000 shares of Common Stock to SCC, representing a payment of approximately $126,358.65.”

AMERICAN REBEL HOLDINGS INC issued 259,925 shares of the Company's common stock of common stock to Streeterville Capital, LLC ("Streeterville") for $389,887.50 of the Exchange Note dated September 10, 2025.

“On February 3, 2026, Streeterville Capital, LLC ("Streeterville") converted $389,887.50 of the Exchange Note dated September 10, 2025 (the "Note") into 51,985 shares of the Company's Series D Convertible Preferred Stock, which were immediately converted into 259,925 shares of the Company's common stock.”

AMERICAN REBEL HOLDINGS INC issued 40,000 shares of the Company's common stock of common stock to Streeterville Capital, LLC ("Streeterville") for $60,000 of the Exchange Note dated September 10, 2025.

“On February 2, 2026, Streeterville Capital, LLC ("Streeterville") converted $60,000 of the Exchange Note dated September 10, 2025 (the "Note") into 8,000 shares of the Company's Series D Convertible Preferred Stock, which were immediately converted into 40,000 shares of the Company's common stock.”

AMERICAN REBEL HOLDINGS INC issued 184,634 shares of Series D Convertible Preferred Stock converted such shares into 923,170 shares of common of common stock.

“On February 2, 2026, holders of 184,634 shares of Series D Convertible Preferred Stock converted such shares into 923,170 shares of common”

AMERICAN REBEL HOLDINGS INC issued 60,000 shares of the Company's Series D Convertible Preferred Stock of preferred stock to five holders of OID promissory notes dated May 27, 2025 for gross principal amount of $450,000.

“On January 30, 2026, five holders of OID promissory notes dated May 27, 2025, in the gross principal amount of $450,000, converted the notes into 60,000 shares of the Company's Series D Convertible Preferred Stock.”

Blackstone Real Estate Income Trust, Inc. issued 565,571 of common stock to accredited investors for aggregate consideration of approximately $8.0 million.

“On February 2, 2026, Blackstone Real Estate Income Trust, Inc. (the "Company") sold unregistered shares of the Company’s common stock (the "Shares") for aggregate consideration of approximately $8.0 million.”

LB PHARMACEUTICALS INC issued pre-funded warrants to purchase up to 1,417,107 shares of warrant to institutional investors (including Balyasny Asset Management L.P., Caligan Partners, Commodore Capital, Deep Track Capital, Nantahala Capital, Pivotal bioVenture Partners, Spruce Street Capital, TCGX, Trails Edge Capital Partners) for $21.1699 per pre-funded warrant.

“to purchase up to 1,417,107 shares of its common stock to a select group of institutional investors in a private placement. The purchase price of each share of common stock is $21.17. The purchase price of each pre-funded warrant is $21.1699, which represents the per share purchase price for the common stock less the $0.0001 per share exercise price for such”

LB PHARMACEUTICALS INC issued 3,306,571 shares of common stock to institutional investors (including Balyasny Asset Management L.P., Caligan Partners, Commodore Capital, Deep Track Capital, Nantahala Capital, Pivotal bioVenture Partners, Spruce Street Capital, TCGX, Trails Edge Capital Partners) for $21.17 per share.

“to purchase up to 1,417,107 shares of its common stock to a select group of institutional investors in a private placement. The purchase price of each share of common stock is $21.17. The purchase price of each pre-funded warrant is $21.1699, which represents the per share purchase price for the common stock less the $0.0001 per share exercise price for such”

urban-gro, Inc. issued 1-for-25 reverse stock split of common stock.

“urban-gro, Inc. (Nasdaq: UGRO) (“urban-gro” or the “Company”) announced today that the Company’s Board of Directors approved a reverse stock split of one share for every twenty-five (25) shares of common stock.”

ExchangeRight Income Fund issued 7,326 of common stock for $200,000.

“Rule 506(c) of Regulation D promulgated thereunder. The following table details the shares sold: Number of Gross Share Class Shares Sold Proceeds Class D Common Shares 7,326 $ 200,000 Forward-Looking Statements Certain statements contained in this Current Report on Form 8-K other than historical facts may be considered “forward-looking statements,” and, as”

FARADAY FUTURE INTELLIGENT ELECTRIC INC. issued common stock to an accredited investor for $10 million.

“the Company has agreed to sell, and the Investor has agreed to purchase, $10 million (the “Subscription Amount”) of Class A common stock”

Edible Garden AG Inc issued 59,114 shares of common stock of common stock to Streeterville Capital, LLC for aggregate stated value of $390,000.

“Stock”), for a total of 59,114 shares of the Company’s common stock, par value $0.0001 per share (“Exchange Shares”). The Preferred Stock had an aggregate stated value of $390,000 (the “Stated Value”), or $1,000 per share. The number of Exchange Shares issued under the Exchange Agreements was determined by dividing the Stated Value by the Nasdaq Minimum”

IR-Med, Inc. issued warrant.

“The information required by this Item 3.02 is included under Item 1.01 of this Current Report on Form 8-K.”

Profusa, Inc. issued common stock.

“today announced that it filed an amendment to its amended and restated certificate of incorporation with the Secretary of State of the State of Delaware to effect a one-for-seventy-five (1:75) reverse stock split of its common stock.”

Sculptor Diversified Real Estate Income Trust, Inc. issued 3,364,353 shares of common stock for $39,311,860.

“On February 2, 2026, Sculptor Diversified Real Estate Income Trust, Inc. (the “Company”) issued the following shares based on the respective net asset value per share as of December 31, 2025. The following table details the shares issued and gross proceeds: Number of Shares Issued Gross Proceeds Class E Shares (1) 3,000,411 $ 35,198,420 Class A Shares 58,803 653,690 Class AA Shares (2) 296,108 3,359,750 Class I-S Shares 9,031 100,000 Total 3,364,353 $ 39,311,860”

Cohen & Steers Income Opportunities REIT, Inc. issued Class P 18,305; Class B 216,894; Class R-I 63,056; Class R-S 34,671 of common stock for $210,000; $2,425,000; $705,000; $400,000.

“On February 2, 2026, Cohen & Steers Income Opportunities REIT, Inc. issued the following shares: Common Shares Number of Shares Sold Aggregate Consideration (1) Class P 18,305 $210,000 Class B 216,894 $2,425,000 Class R-I 63,056 $705,000 Class R-S 34,671 $400,000”

Blue Owl Real Estate Net Lease Trust issued 18,490,827 common shares of common stock to investors for gross proceeds of approximately $195.8 million.

“On February 2, 2026, Blue Owl Real Estate Net Lease Trust (the “ Company ,” “ ORENT ” “ we ” or “ us ”) sold an aggregate of 18,490,827 of its common shares for gross proceeds of approximately $195.8 million, based on net asset value per share as of December 31, 2025. The offers and sales of these shares were exempt from the registration provisions of the Securities Act of 1933, as amended, pursuant to Section 4(a)(2), Regulation D and/or Regulation S thereunder. The following table details the common shares sold: Common shares Number of Shares Sold Gross Proceeds Class S 8,556,172 $90,456,799* Class N 2,009,996 $21,595,918* Class D 96,507 $1,000,000 Class I 7,828,152 $82,748,268 *Gross proceeds for Class S and Class N shares include aggregate commissions, which consist of the sales load and dealer manager fees, of $634,109 and $322,518 , respectively.”

North Haven Net REIT issued 2,034,255 common shares of common stock for aggregate consideration of approximately $41.9 million.

“the Company sold an aggregate of 2,034,255 common shares (the “Shares”) for aggregate consideration of approximately $41.9 million, plus applicable upfront selling commissions and dealer manager fees, at the most recently determined net asset value per share”

New Mountain Net Lease Trust issued 1,140,622 of its common shares of beneficial interest of common stock for aggregate consideration of approximately $22.84 million.

“on February 2, 2026, the Company sold an aggregate of 1,140,622 of its common shares of beneficial interest, par value $0.01 per share (the “Shares”), for aggregate consideration of approximately $22.84 million”

Stonepeak-Plus Infrastructure Fund LP issued 1,043,983 Class A-1a Units; 18,139 Class A-1c Units; 104,174 Class I-1 Units of unit to third party investors for aggregate consideration of approximately $35,950,007.

“On January 2, 2026, Stonepeak-Plus Infrastructure Fund LP (the “Fund”) sold unregistered limited partnership units (the “Units”) to third party investors for aggregate consideration of approximately $35,950,007.”

BlackRock Monticello Debt Real Estate Investment Trust issued 407,132.6902 common shares of common stock for aggregate consideration of $10,210,000.

“on February 2, 2026, the Company sold an aggregate of 407,132.6902 common shares (the “Shares”) for aggregate consideration of $10,210,000, plus applicable upfront selling commissions and dealer manager fees.”

ISQ Open Infrastructure Co LLC issued Class Number of Shares Sold* Aggregate Net Consideration* Series I F-S TE Shares 215,009 $ 6,520,000 ... Series II F-S Shares 67,927 $ 2,060,000 of common stock to accredited investors and non-U.S. investors for total aggregate net consideration of $28,449,310.

“of January 1, 2026 held by third parties. * Share and dollar amounts rounded to the nearest whole number. The Company issued such shares for total aggregate net consideration of $28,449,310 (the “Proceeds”). The offer and sale of the shares above were exempt from the registration provisions of the Securities Act of 1933, as amended, by virtue of Section 4(a)(2),”

Rithm Perpetual Life Residential Trust issued 320,600.239 common shares of common stock to accredited investors for aggregate consideration of approximately $6.6 million.

“on February 2, 2026, the Company sold an aggregate of 320,600.239 common shares (the “Shares”) for aggregate consideration of approximately $6.6 million”

Colombier Acquisition Corp. III issued 150,000 units (the Private Placement Units) of unit to Colombier Sponsor III LLC (the Sponsor) for $10.00 per Private Placement Unit.

“Simultaneously with the closing of the IPO, pursuant to the Private Placement Units Purchase Agreement, the Company completed the private sale of an aggregate of 150,000 units (the “ Private Placement Units ”) to the Sponsor at a purchase price of $10.00 per Private Placement Unit, generating gross proceeds to the Company of $1,500,000.”

LEE ENTERPRISES, Inc issued an aggregate of 15,384,615 shares (the 'Base PIPE Common Shares') and an additional 615,385 shares (the 'Fee Reimbursement Shares') of common stock to David Hoffmann (Anchor Investor) and certain additional investors for at a purchase price of $3.25 per share.

“On February 5, 2026, the Company closed (the “Closing”) its previously announced private placement (the “Private Placement”) and, pursuant to the terms of that certain stock purchase agreement (the “Purchase Agreement”) by and among the Company, David Hoffmann (the “Anchor Investor”) and certain additional investors (the “Other Investors” and, together with the Anchor Investor, the “Investors”), sold an aggregate of 15,384,615 shares (the “Base PIPE Common Shares”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”), at a purchase price of $3.25 per share to the Investors. In connection with the Closing, pursuant to the terms of the Purchase Agreement, the Company issued an additional 615,385 shares of Common Stock (the “Fee Reimbursement Shares” and, together with the Base PIPE Common Shares, the “Shares”) as reimbursement of certain of the Anchor Investor’s expenses at a price of $3.25 per share.”

Agassi Sports Entertainment Corp. issued 2,097,740 shares of common stock of common stock to James Askew.

“On February 4, 2026, James Askew, a member of the Board of Directors of the Company exercised warrants to purchase an aggregate of 2,269,583 shares of the Company’s common stock with an exercise price of $0.397 per share (the “ Warrants ”) on a cashless basis. In connection with such exercise, the Company issued to Mr. Askew a net of 2,097,740 shares of common stock, after the forfeiture of 171,843 warrant shares to the Company in satisfaction of the aggregate exercise price, based on the fair market value of the Company’s common stock on the exercise date, as determined in accordance with the terms of the Warrants.”

Agassi Sports Entertainment Corp. issued 200,000 shares of common stock of warrant to a third party consultant.

“On February 3, 2026, Agassi Sports Entertainment Corp. (the “ Company ”, “ we ” and “ us ”), entered into a consulting agreement with a third party consultant and granted the consultant warrants to purchase up to 200,000 shares of common stock of the Company, with a three year term and a $5.00 per share exercise price, including cashless exercise rights, exercisable as to 100,000 such warrant shares immediately and 100,000 such warrant shares on the one year anniversary of the grant.”

SMITH MICRO SOFTWARE, INC. issued warrant to Smith (Smith Living Trust, for which William W. Smith, Jr. and Dieva L. Smith serve as co-trustees) for approximately $185,021 for the purchase of the accompanying Warrant.

“On February 3, 2026, the Company and Smith completed a closing of a loan transaction under the Note Agreement, and the Company issued a Note and a Warrant to Smith pursuant to the terms of the Note Agreement. The Warrant has an exercise price of $0.68 and will be exercisable during the period beginning August 3, 2026 and ending August 3, 2031. The gross proceeds to the Company from the closing totals approximately $1,000,000 (comprised of approximately $814,979 as a loan and approximately $185,021 for the purchase of the accompanying Warrant)”

SANGAMO THERAPEUTICS, INC issued 23,809,523 shares of common stock of warrant to investor in the Offering for reduced from $1.00 to $0.4719.

““Purchase Warrants” and together with the Pre-Funded Warrants, the “Warrants”). The combined offering price of each share of Common Stock and accompanying Purchase Warrant is $0.4719. The combined offering price of each Pre-Funded Warrant and accompanying Purchase Warrant is $0.4619. The Common Stock and Pre-Funded Warrants are being sold in combination with”

COLUMBUS MCKINNON CORP issued 800,000 Preferred Shares of preferred stock to CD&R Investor for $800.0 million or $1,000 per Preferred Share.

“On February 3, 2026, as contemplated by the Investment Agreement, the Company issued and sold to the CD&R Investor 800,000 Preferred Shares for an aggregate purchase price of $800.0 million or $1,000 per Preferred Share, pursuant to the Investment Agreement.”

Cuentas Inc. issued warrant.

“Cuentas, Inc. (the “Company”) today announced that it had extended the expiration date of its publicly traded warrants (OTCID: CUENW) (the “Warrants”) from February 4, 2026 to June 30, 2026.”

Vivakor, Inc. issued Agreement Shares of common stock to accredited investors (Lenders).

“the Company entered into the Agreements and will issue the Agreement Shares. The Agreement Shares were issued as restricted stock with a standard Rule 144 restrictive legend. The issuances of the foregoing securities were exempt from registration pursuant to Section 4(a)(2) of the Securities Act promulgated thereunder as the Lenders are accredited investors and familiar with our operations”

ADIAL PHARMACEUTICALS, INC. issued common stock.

“the information regarding the Reverse Stock Split (as defined below) contained in Item 5.03 of this Current Report on Form 8-K is incorporated by reference herein.”

PAVmed Inc. issued warrants (the “ Warrant ”) to purchase an additional 30,000 shares of Series D Preferred Stock of warrant to certain accredited investors for $100,000 of its investment.

“with certain accredited investors (the “ Investors ”) and, pursuant to and concurrently with the execution of the Subscription Agreements, sold to the Investors, for an aggregate purchase price of $30 million, (i) 30,000 shares of the Company’s newly designated Series D Convertible Preferred Stock, par value $0.001 per share (the “ Series D Preferred Stock ”), and (ii) warrants (the “ Warrant ”) to purchase an additional 30,000 shares of Series D Preferred Stock, with each investor receiving 100 shares of Series D Preferred Stock and a warrant to purchase 100 shares of Series D Preferred Stock for each $100,000 of its investment”

PAVmed Inc. issued 30,000 shares of the Company's newly designated Series D Convertible Preferred Stock of preferred stock to certain accredited investors for aggregate purchase price of $30 million.

“On February 3, 2026, PAVmed Inc. (the “ Company ”) entered into subscription agreements (the “ Subscription Agreements ”) with certain accredited investors (the “ Investors ”) and, pursuant to and concurrently with the execution of the Subscription Agreements, sold to the Investors, for an aggregate purchase price of $30 million, (i) 30,000 shares of the Company’s newly designated Series D Convertible Preferred Stock”

WRAP TECHNOLOGIES, INC. issued 2,500,000 shares of Common Stock of warrant to accredited investors for $2.00 per Common Share and accompanying Common Warrant.

“On February 2, 2026, Wrap Technologies, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with certain accredited investors (collectively, the “Purchasers”) for the issuance and sale in a private placement (the “Private Placement”) of (i) an aggregate of 1,700,000 shares (the “Common Shares”) of common stock of the Company, par value $0.0001 per share (the “Common Stock”), (ii) pre-funded warrants to purchase up to 800,000 shares of Common Stock (the “Pre-Funded Warrants”), with an exercise price of $0.0001 per share, and (iii) common warrants to purchase up to 2,500,000 shares of Common Stock (the “Common Warrants”, together with the Pre-Funded Warrants, the “Warrants”), with an exercise price of $2.30 per share.”

WRAP TECHNOLOGIES, INC. issued 800,000 shares of Common Stock of warrant to accredited investors for $1.9999 per Pre-Funded Warrant and accompanying Common Warrant.

“On February 2, 2026, Wrap Technologies, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with certain accredited investors (collectively, the “Purchasers”) for the issuance and sale in a private placement (the “Private Placement”) of (i) an aggregate of 1,700,000 shares (the “Common Shares”) of common stock of the Company, par value $0.0001 per share (the “Common Stock”), (ii) pre-funded warrants to purchase up to 800,000 shares of Common Stock (the “Pre-Funded Warrants”), with an exercise price of $0.0001 per share, and (iii) common warrants to purchase up to 2,500,000 shares of Common Stock (the “Common Warrants”, together with the Pre-Funded Warrants, the “Warrants”), with an exercise price of $2.30 per share.”

WRAP TECHNOLOGIES, INC. issued 1,700,000 shares of common stock to accredited investors for $2.00 per share.

“On February 2, 2026, Wrap Technologies, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with certain accredited investors (collectively, the “Purchasers”) for the issuance and sale in a private placement (the “Private Placement”) of (i) an aggregate of 1,700,000 shares (the “Common Shares”) of common stock of the Company, par value $0.0001 per share (the “Common Stock”), (ii) pre-funded warrants to purchase up to 800,000 shares of Common Stock (the “Pre-Funded Warrants”), with an exercise price of $0.0001 per share, and (iii) common warrants to purchase up to 2,500,000 shares of Common Stock (the “Common Warrants”, together with the Pre-Funded Warrants, the “Warrants”), with an exercise price of $2.30 per share.”

Dayforce, Inc. issued 1,950,866 shares of Company Common Stock of common stock to holders of the outstanding exchangeable shares of Ceridian AcquisitionCo ULC not held by the Company or its subsidiaries for in exchange for all of the outstanding exchangeable shares of Ceridian AcquisitionCo ULC not held by the Company or its subsidiaries on a 1-1 basis.

“On February 3, 2026, the Company issued 1,950,866 shares of Company Common Stock to holders of the outstanding exchangeable shares of Ceridian AcquisitionCo ULC not held by the Company or its subsidiaries, in exchange for all of the outstanding exchangeable shares of Ceridian AcquisitionCo ULC not held by the Company or its subsidiaries on a 1-1 basis.”

Stellus Private Credit BDC issued 183,902 common shares of common stock to investors for aggregate offering price of $2,797,150.88.

“On February 2, 2026, Stellus Private Credit BDC (the “Company”) issued 183,902 common shares of beneficial interest (the “Shares”) of the Company for an aggregate offering price of $2,797,150.88.”

Starwood Credit Real Estate Income Trust issued 367,926.345 of its common shares of common stock to accredited investors for aggregate consideration of approximately $7.5 million.

“the Company sold an aggregate of 367,926.345 of its common shares of beneficial interest, par value $0.01 per share (the “Shares”), for aggregate consideration of approximately $7.5 million at a price per Class S Share and Class I Share equal to $20.2147 and $20.1665, respectively”

GigCapital7 Corp. issued 14,800 private placement units of unit to unspecified for conversion of entire principal balance of Working Capital Note.

“An aggregate of 14,800 private placement units of the Company would be issued if the entire principal balance of the Working Capital Note is converted.”

Apollo IG Core Replacement, L.P. issued securities to accredited investors and/or non-U.S. persons for $505.0 million in cash.

“On February 2, 2026, Apollo IG Core Replacement, L.P. (“Apollo IG Core”) issued unregistered limited partnership interests (the “Interests”) for aggregate consideration of approximately $505.0 million in cash.”

White Pearl Acquisition Corp. issued 290,000 private units of unit to White Pearl Group Limited (the Sponsor) for at a price of $10.00 per Private Unit, generating total proceeds of $2,900,000.

“Simultaneously with the closing of the IPO, the Company consummated the private placement (“Private Placement”) with White Pearl Group Limited, the Company’s sponsor (the “Sponsor”), of 290,000 private units (the “Private Units”) at a price of $10.00 per Private Unit, generating total proceeds of $2,900,000.”

CERES ORION L.P. issued 789.4500 units of unit for $2,750,000.

“On February 1, 2026, the registrant issued 789.4500 units of limited partnership interest (“LP Units”) in exchange for $2,750,000 in transactions that was not registered under the Securities Act.”

Our Bond, Inc. issued warrants to purchase a total of 25,000,000 shares of our common stock of warrant to Ascent Partners Fund LLC for issued together with Series D Preferred Stock for aggregate consideration.

“At the initial closing under the SPA on October 27, 2025, we issued 109,891 shares of Series D Preferred Stock for consideration of $1,000,000, together with warrants to purchase a total of 25,000,000 shares of our common stock exercisable at a price of $12.35 per share.”

Our Bond, Inc. issued 549,451 shares of Series D Preferred Stock of preferred stock to Ascent Partners Fund LLC for total consideration of $4,700,000 across multiple closings.

“On October 27, 2025, we entered into a Securities Purchase Agreement (the "SPA") with Ascent Partners Fund LLC ("Ascent") for the issuance and sale of a total of 549,451 shares of Series D Preferred Stock and warrants to purchase of a total of 25,000,000 shares of our common stock.”

Steele Creek Capital Corp issued common stock for approximately $70,000.00.

“On February 2, 2026, the Company sold approximately $70,000.00 worth of shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”),”

C2 Blockchain, Inc. issued 45,000,000 restricted shares of common stock to Mendel Holdings, LLC for in full satisfaction of all services rendered.

“the Board executed a unanimous written consent ratifying and correcting the prior authorization to reflect the issuance of 45,000,000 restricted shares of the Company’s common stock, par value $0.001 per share, to Mendel Holdings in full satisfaction of all services rendered.”

LITHIUM AMERICAS CORP. issued 8,656,509,695 Non-Voting Units of warrant to United States Department of Energy for $0.0001 per Non-Voting Unit exercise price.

“the “A&R JV Warrant”), providing for, among other things, the right to purchase non-voting units of the LAC-GM Joint Venture (“Non-Voting Units”) at an exercise price of $0.0001 per Non-Voting Unit, exercisable for ten years from the date of issuance of the A&R JV Warrant, subject to customary anti-dilution adjustments and other terms set forth in the A&R”